DoubleLine ETF Adviser’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.54M Sell
27,527
-3,383
-11% -$396K 1.46% 15
2026
Q1
$3.72M Buy
+30,910
New +$3.57M 1.41% 15

Other funds holding MRK

DoubleLine ETF Adviser's MRK Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $396K and leaving 27,527 shares worth $3.54M. The position accounts for 1.46% of the portfolio, ranked #15.

DoubleLine ETF Adviser first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.72M in Q1 2026. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • DoubleLine ETF Adviser held 27,527 shares of Merck worth $3.54M as of Q2 2026.
  • DoubleLine ETF Adviser sold 3,383 Merck shares in Q2 2026, an estimated $396K.
  • Merck made up 1.46% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #15 holding.
  • DoubleLine ETF Adviser first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
  • DoubleLine ETF Adviser's Merck position peaked at $3.72M in Q1 2026.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.